Replying to the part of your post referring to having to do another pp. They have .38 warrants out there that equals just over 3.9 million. They will get those cashed 1st before any more public financing is done. Use that as a bench mark of where the sp is going. But keep in ming that those warrants are not expiring until april 2020.
If in fact they do raise more $$ it wont be from a pp, it most likely will come from an investment firm, and we wont be able to get in on it.
Roughly a year ago the sp was at .42. Its not impossible to see that again this year.
Thanks Nova. I just went into Sedar and read through their December MD&A. They haven't even met with the FDA yet but they state they feel confident that they will have to do a comparative study. Then they went ahead and made it look definitive by stating that a "study is planned" in their corporate presentation and press released "an updated corporate presentation."
And the expected completion dates for the functional unit and verified unit have been FURTHER DELAYED: the functional unit is now expected to be completed by Q1 2019 and the verified unit by late Q2 2019. The August MD&A stated Q4 2018 for the functional unit and Q1 for the verified unit.
Also, the December MD&A no longer states that the their system can produce images in less than 15 minutes vs the full hour required by current technology. It just states that it can produce images in "less time." NOT GOOD.
And here's the cherry on the cake: the December MD&A states that their consulting fees have increased by $1.4 million. They engaged "numerous consultants" to provide services primarily related to raising capital and public relations (PR), specifically INTERNET MARKETING, RESEARCH REPORTS,NEWS and PRESS RELEASES and their DISTRIBUTION. it further states that the company is CONTINUING with its ONGOING communications and marketing programs to efficiently increase the awareness of progress of the company.
Has anyone seen any of this Internet marketing that they claim they have done? What communications and marketing programs have they done? I have seen NOTHING. They spent 1.4 million and the stock has CRASHED over the past six months. Everyone should be writing to Jim Hutchens and the CFO John Vacha demanding to know where this money has gone. What is 100% clear is that whatever they have done has obviously FAILED.
Jim Hutchen's email: jhutchens@imaginmedical.com Jon Vacha's email: jvacha@imaginmedical.com
News 
Market Data 
Discover 
